FundaMental Pharma GmbH. (4/11/24). "Press Release: FundaMental Pharma Appoints Dr. Dirk Beher as Chief Executive Officer". Heidelberg. |
2024-04-11 |
OpGen, Inc.. (3/25/24). "Press Release: OpGen Announces Acquisition of Preferred Stock by David Lazar". Rockville, MD. |
2024-03-25 |
ProteinDistillery GmbH. (3/7/24). "Press Release: ProteinDistillery Raises €15 Million in Seed Funding". Esslingen & Berlin. |
2024-03-07 |
Affimed N.V.. (3/6/24). "Press Release: Affimed Announces 1-for-10 Reverse Stock Split". Mannheim. |
2024-03-06 |
Cyclize GmbH. (2/21/24). "Press Release: ClimateTech Startup Cyclize Secures €5 Million in Seed Funding for Revolutionary Plastic Recycling Technology". Munich. |
2024-02-21 |
CureVac N.V.. (1/17/24). "Press Release: CureVac CEO Alexander Zehnder Acquires Common Shares of Company Stock". Tübingen & Boston, MA. |
2024-01-17 |
Roche Deutschland Holding GmbH. (1/10/24). "Press Release: Prof. Hagen Pfundner wird zum 1. Mai 2024 Vorsitzender der Roche Deutschland Holding GmbH". |
2024-01-10 |
CureVac N.V.. (1/5/24). "Press Release: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform". Tübingen & Boston, MA. |
2024-01-05 |
Bruker Corporation. (1/3/24). "Press Release: Bruker Acquires Electron Microscopy Company Nion". Billerica, MA. |
2024-01-03 |
Affimed N.V.. (1/3/24). "Press Release: Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck". Mannheim. |
2024-01-03 |
CureVac N.V.. (12/19/23). "Press Release: CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE". Tübingen. |
2023-12-19 |
EMBL. (12/14/23). "Press Release: Using Artificial Intelligence to Discover Therapeutic Antibodies". |
2023-12-14 |
Heidelberg Pharma AG. (11/29/23). "Press Release: Heidelberg Pharma Announces Changes to the Executive Management Board. CEO Dr. Jan Schmidt-Brand to Retire". Ladenburg. |
2023-11-29 |
WMT AG. (11/28/23). "Press Release: FS Investment Acquires a Stake in WMT AG". Düsseldorf & Heidelberg. |
2023-11-28 |
OpGen, Inc.. (11/7/23). "FORM 8-K: OpGen’s Wholly Owned Subsidiaries Curetis GmbH and Ares Genetics GmbH Filed for Bankruptcy Protection". |
2023-11-07 |
AATec Medical GmbH. (10/31/23). "Press Release: AATec Medical and Beurer Enter Development Collaboration for Inhaled Alpha-1 Antitrypsin". Munich. |
2023-10-31 |
CureVac N.V.. (9/28/23). "Press Release: CureVac Reports Progress in Intellectual Property Infringement Case Against BioNTech in Germany". Tübingen & Boston, MA. |
2023-09-28 |
Rentschler Biopharma SE. (9/19/23). "Press Release: Rentschler Biopharma Appoints Benedikt von Braunmuehl as Chief Executive Officer". Laupheim, Stevenage & Milford, MA. |
2023-09-19 |
SHS Gesellschaft für Beteiligungsmanagement mbH. (9/13/23). "Press Release: Healthcare Specialist SHS Capital Announces Final Closing of Its Oversubscribed Sixth Fund Generation Totaling EUR 270 Million". Tübingen. |
2023-09-13 |
Rentschler Biopharma SE. (8/23/23). "Press Release: Collaboration to Improve Process Analytical Technologies and AAV Manufacturing for Gene Therapies". Stevenage, London & Laupheim. |
2023-08-23 |
CureVac N.V.. (8/17/23). "Press Release: CureVac Announces Financial Results for the Second Quarter and First Half of 2023 and Provides Business Update". Tübingen & Boston, MA. |
2023-08-17 |
AaviGen GmbH. (7/26/23). "Press Release: AaviGen Raises 17 Million € in Second Financing Round to Advance Precision Gene Therapies for Heart Failure towards the Clinical Stage". Heidelberg. |
2023-07-26 |
LimmaTech Biologics AG. (7/20/23). "Press Release: LimmaTech Biologics Appoints Franz-Werner Haas as CEO to Lead Company into Next Stage of Corporate Growth". Schlieren. |
2023-07-20 |
CureVac N.V.. (7/14/23). "Press Release: CureVac Announces Update to the Management Team". Tübingen & Boston, MA. |
2023-07-14 |
TolerogenixX GmbH. (7/6/23). "Press Release: TolerogenixX Expands Phase II Immune-tolerance Trial and Closes EUR 12 million Series A Financing". |
2023-07-06 |
Heidelberg Pharma AG. (6/29/23). "Press Release: Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics (ad hoc announcement)". Ladenburg. |
2023-06-29 |
SHS Gesellschaft für Beteiligungsmanagement mbH. (6/22/23). "Press Release: Healthcare Specialist SHS Capital Invests €18 Mio in MESI Medical to Bring Digital Diagnostics to the Core of Healthcare Services". Tübingen. |
2023-06-22 |
CureVac N.V.. (5/19/23). "Press Release: CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech". Tübingen. |
2023-05-19 |
Bruker Corporation. (5/8/23). "Press Release: Bruker Announces Acquisition of Zontal to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions". Billerica, MA. |
2023-05-08 |
Bicycle Therapeutics plc. (5/4/23). "Press Release: Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets". Cambridge & Boston, |
2023-05-04 |
Boehringer Ingelheim. (4/24/23). "Press Release: Boehringer Ingelheim Inaugurates Largest European Development Centre for Biotechnology". Ingelheim. |
2023-04-24 |
InSphero AG. (3/31/23). "Press Release: InSphero Accelerates Launch of Cryopreserved 3D Microtissue Platform with New Investment Round Led by Zeiss Ventures". Zürich. |
2023-03-31 |
SHS Gesellschaft für Beteiligungsmanagement mbH. (3/2/23). "Press Release: More Patient Safety with Simulators for Cardiologists – SHS Invests 10 Million Euro in Swiss Simulands AG". Tübingen. |
2023-03-02 |
VisionHealth GmbH. (2/27/23). "Press Release: VisionHealth Raises 3 Million Euro to Finance Extended COPD and Asthma Study for Market Preparation of Kata, an Innovative Digital Therapeutic for Improved Inhalation". Munich. |
2023-02-27 |
Alentis Therapeutics AG. (2/17/23). "Press Release: Alentis Therapeutics Makes Key Leadership Appointments". Basel. |
2023-02-17 |
CureVac N.V.. (2/8/23). "Press Release: CureVac Announces Pricing of Upsized Public Offering of Common Shares". Tübingen & Boston, MA. |
2023-02-08 |
CureVac N.V.. (2/6/23). "Press Release: CureVac Announces Proposed Public Offering of Common Shares". Tübingen & Boston, MA. |
2023-02-06 |
CureVac N.V.. (1/10/23). "Press Release: CureVac Appoints Alexander Zehnder as CEO from April 1, 2023". Mainz & London. |
2023-01-10 |
CureVac N.V.. (1/6/23). "Press Release: CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs". Tübingen & Boston, MA. |
2023-01-06 |
Bruker Corporation. (1/5/23). "Press Release: Bruker Announces Acquisition of Acquifer Imaging GmbH". Heidelberg. |
2023-01-05 |
High-Tech Gründerfonds Management GmbH. (12/7/22). "Press Release: Variolytics Receives Seven-figure Seed Funding for Climate-neutral Wastewater Treatment Plants". Stuttgart. |
2022-12-07 |
faCelliate GmbH. (11/30/22). "Press Release: faCellitate Appoints Christoph Petry, Ph.D. to Become Managing Director and CEO". Mannheim. |
2022-11-30 |
Oxford Biomedica plc. (11/22/22). "Press Release: Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer". Oxford. |
2022-11-22 |
High-Tech Gründerfonds Management GmbH. (11/17/22). "Press Release: FundaMental Pharma Launches with EUR 10 Million in Seed Financing Led by BGV and Thuja Capital to Advance a First-in-Class Neuroprotectant". Heidelberg. |
2022-11-17 |
Rentschler Biopharma SE. (11/16/22). "Press Release: Rentschler Biopharma Appoints Christiane Bardroff as Chief Operating Officer and Member of the Executive Board". Laupheim. |
2022-11-16 |
Affimed N.V.. (11/3/22). "Press Release: Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101". Heidelberg & San Diego, CA. |
2022-11-03 |
Affimed N.V.. (11/1/22). "Press Release: Affimed to Present at the 2022 Jefferies London Healthcare Conference". Heidelberg. |
2022-11-01 |
Kizoo Technology Capital GmbH. (10/26/22). "Press Release: Kizoo Invests in Rejuvenation Startup MoglingBio". Berlin & Ulm. |
2022-10-26 |
Boehringer Ingelheim. (10/20/22). "Press Release: University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs". Tübingen & Ingelheim. |
2022-10-20 |
faCelliate GmbH. (10/11/22). "Press Release: faCellitate Starts Marketing New 384-well Spheroid Microplate". Mannheim. |
2022-10-11 |
T-Curx GmbH. (9/15/22). "Press Release: Caroline Burger, PhD, Appointed as T-Curx' Global Head Business Development". Würzburg. |
2022-09-15 |
Forever Healthy Foundation gGmbH. (9/15/22). "Press Release: Rejuvenation Startup Summit 2022 Announces Program and Speakers". |
2022-09-15 |
Heidelberg Pharma AG. (9/9/22). "Press Release: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate". Ladenburg. |
2022-09-09 |
faCelliate GmbH. (9/7/22). "Press Release: faCellitate, a BASF Spin-off, Closes a €3.7m Seed Round Led by Sarstedt and HTGF". Mannheim. |
2022-09-07 |
EMBL. (9/6/22). "Press Release: ERC Proof-of-Concept Grant Provides Way to Realise Commercial Potential of ‘SpaceM’ Technology". |
2022-09-06 |
Affimed N.V.. (9/1/22). "Press Release: Affimed to Present at Upcoming Investor Conferences". Heidelberg. |
2022-09-01 |
Heidelberg Pharma AG. (8/30/22). "Press Release: Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure [ Not for US, CA, et al.]". Ladenburg. |
2022-08-30 |
SHS Gesellschaft für Beteiligungsmanagement mbH. (8/18/22). "Press Release: SHS Appoints Manfred Ulmer-Weber to the Management Board". Tübingen. |
2022-08-18 |
Rentschler Biopharma SE. (8/10/22). "Press Release: Rentschler Biopharma Expands Leadership Team with Senior-level Hires". Laupheim. |
2022-08-10 |
Sartorius Stedim Biotech S.A.. (7/21/22). "Press Release: Half-year Results 2022 of Sartorius Stedim Biotech. Sales Revenue up 22.1 Percent in Constant Currencies, Underlying EBITDA Margin 35.2 Percent
". Aubagne. |
2022-07-21 |
Sartorius AG. (7/21/22). "Press Release: Sartorius Remains on Growth Track. Figures for the First Half of 2022 – Sales Revenue up 20.9 Percent in Constant Currencies, Underlying
EBITDA up 25.6 Percent, Underlying EBITDA Margin 33.9 Percent". Göttingen. |
2022-07-21 |
SHS Gesellschaft für Beteiligungsmanagement mbH. (7/18/22). "Press Release: More than 220 Million Euros for Growth and Succession Investments in European Healthcare Companies". |
2022-07-18 |
Heidelberg Pharma AG. (7/13/22). "Press Release: Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate (ad hoc)". Ladenburg. |
2022-07-13 |
CureVac N.V.. (7/5/22). "Press Release: CureVac Files Patent Infringement Lawsuit in Germany against BioNTech". Tübingen & Boston, MA. |
2022-07-05 |
Wacker Chemie AG. (7/5/22). "Press Release: Wacker to Start Construction of Competence Center for mRNA Actives at Halle Site". Tübingen & Boston, MA. |
2022-07-05 |
Evotec SE. (7/4/22). "Press Release: Evotec SE – Translational BRIDGE Partnership beLAB2122 Selects Oncology Project from Goethe University Frankfurt". Hamburg. |
2022-07-04 |
Pepperprint GmbH. (6/9/22). "Press Release: Pepperprint GmbH Introduces Novel Biomarker Set for Rheumatoid Arthritis Diagnosis at the 13th International Congress on Autoimmunity". Heidelberg. |
2022-06-09 |
CureVac N.V.. (6/8/22). "Press Release: CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform". Tübingen & Amsterdam. |
2022-06-08 |
BioInnovation Institute (BII). (6/2/22). "Press Release: High-quality Project from EMBL Is the First to Enter the Bio Studio Program". |
2022-06-02 |
Max Planck Society. (5/27/22). "Press Release: Amazon and Max Planck Society Establish Science Hub". |
2022-05-27 |
CureVac N.V.. (5/25/22). "Press Release: CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development". Tübingen & Ghent. |
2022-05-25 |
Forever Healthy Foundation gGmbH. (5/19/22). "Press Release: Rejuvenation Startup Summit Premieres October, 14-15, 2022 in Berlin". |
2022-05-19 |
NanoTemper Technologies GmbH. (5/18/22). "Press Release: NanoTemper Technologies Welcomes Andreas Schmitz as Its First Chief Human Resources Officer". Munich. |
2022-05-18 |
SHS Gesellschaft für Beteiligungsmanagement mbH. (5/9/22). "Press Release: SHS Strengthens Finance Team. Lukas Maucher Joins Tübingen-based Private Equity Investor as CFO". |
2022-05-09 |
Bruker Corporation. (5/9/22). "Press Release: Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets". London. |
2022-05-09 |
Corden Pharma International GmbH. (5/2/22). "Press Release: Astorg to Acquire Leading Pharmaceutical Contract Development & Manufacturing Organization CordenPharma from ICIG". Basel. |
2022-05-02 |
SHS Gesellschaft für Beteiligungsmanagement mbH. (4/22/22). "Press Release: SHS and Yabeo Invest in the Leading Scandinavian Digital Health Platform Dr.Dropin". Tübingen & Oslo. |
2022-04-22 |
CureVac N.V.. (4/21/22). "Press Release: CureVac and GSK’s Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study". Tübingen & Boston, MA. |
2022-04-21 |
SHS Gesellschaft für Beteiligungsmanagement mbH. (4/21/22). "Press Release: SHS Sells Shares in Bochum-based Phenox GmbH, a Leading Manufacturer of Instruments and Implants for the Treatment of Stroke". Tübingen. |
2022-04-21 |
Symrise AG. (4/14/22). "Press Release: Symrise Successfully Places €750 million ESG-linked Promissory Loan Notes". Holzminden. |
2022-04-14 |
Affimed N.V.. (4/13/22). "Press Release: Affimed Announces Pricing of Upsized $90 Million Public Offering of Common Shares". Heidelberg. |
2022-04-13 |
Affimed N.V.. (4/12/22). "Press Release: Affimed Announces Proposed Public Offering of Common Shares". Heidelberg. |
2022-04-12 |
CureVac N.V.. (4/11/22). "Press Release: CureVac and GSK Enter into Pandemic Preparedness Contract with German Government". Tübingen & Boston, MA. |
2022-04-11 |
Affimed N.V.. (4/10/22). "Press Release: Affimed Presents Updated Clinical Data from Phase 1/2 Study of AFM13 Precomplexed with Cord Blood-Derived NK Cells at AACR Annual Meeting". Heidelberg. |
2022-04-10 |
Mireca Medicines GmbH. (4/8/22). "Press Release: Mireca Signs Transformative Deal with Nasdaq-listed Graybug Vision". Tübingen. |
2022-04-08 |
Affimed N.V.. (4/8/22). "Press Release: Affimed Presents Findings from the Dose-escalation Phase of the First-in-human Study of AFM24 in Patients with EGFR-positive Solid Tumors". Heidelberg. |
2022-04-08 |
Bruker Corporation. (4/5/22). "Press Release: Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies". Billerica, MA. |
2022-04-05 |
Affimed N.V.. (3/31/22). "Press Release: Affimed Reports 2021 Financial Results and Highlights Recent Operational Progress". Heidelberg. |
2022-03-31 |
CureVac N.V.. (3/30/22). "Press Release: CureVac and GSK Start Clinical Development of Second-generation COVID-19 Vaccine Candidate, CV2CoV". Tübingen & Boston, MA. |
2022-03-30 |
Veraxa Biotech GmbH. (3/22/22). "Press Release: Torsten Buergermeister Joins Veraxa Biotech GmbH as Chief Financial Officer". Heidelberg. |
2022-03-22 |
Heidelberg Pharma AG. (3/10/22). "Press Release: Heidelberg Pharma Receives Milestone Payment from Partner Magenta for Dosing the First Patient with MGTA-117". Ladenburg. |
2022-03-10 |
CureVac N.V.. (3/1/22). "Press Release: CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer". Tübingen & Boston, MA. |
2022-03-01 |
Heidelberg Pharma AG. (2/28/22). "Press Release: Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment". Ladenburg. |
2022-02-28 |
FZI Forschungszentrum Informatik. (2/21/22). "Press Release: Busy Bees in Search of Data. OCELI Project Makes Causes of Bee Mortality Measurable". Karlsruhe. |
2022-02-21 |
Heidelberg Pharma AG. (2/17/22). "Press Release: Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini (ad hoc)". Ladenburg. |
2022-02-17 |
SHS Gesellschaft für Beteiligungsmanagement mbH. (2/15/22). "Press Release: SHS Sells Leading Enzyme Engineering Company c-LEcta GmbH to Kerry Group". Tübingen. |
2022-02-15 |
Medix Biochemica Oy. (2/1/22). "Press Release: Medix Biochemica Expands Its Molecular Diagnostics Business through the Acquisition of myPOLS Biotec". Espoo. |
2022-02-01 |
ProtaGene GmbH. (1/12/22). "Press Release: Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene". Heilbronn, Heidelberg & Boston, MA. |
2022-01-12 |
Apogenix AG. (12/9/21). "Press Release: Apogenix Receives €20.7 Million in Public Funding for Pivotal Study and Preparation for Market Production of Asunercept for the Treatment of COVID-19". Heidelberg. |
2021-12-09 |
Roche. (12/1/21). "Press Release: Roche Completes Purchase Agreement with Long-term Partner TIB Molbiol to Expand PCR-test Portfolio in the Fight against New Infectious diseases". Basel. |
2021-12-01 |